Common shares of Apimeds Pharmaceuticals US, Inc. (trading under the ticker symbol APUS on the NYSE American exchange) trade at approximately $4.91 per share. Intraday equity values fluctuate dynamically throughout active trading sessions based on low-float micro-cap volume, healthcare sector sentiment, periodic corporate disclosures, and broader market liquidity conditions.